After obtaining its necessary cannabis exporting licenses, a Canadian producer will begin shipping medical marijuana oils to Australia.

On Tuesday (July 2) Aleafia Health (TSX:ALEF,OTCQX:ALEAF) announced that starting in August 2019 it will begin shipping its own branded medical cannabis oils to CannaPacific, its Australia-based partner, for distribution in the Australian market.


Aleafia Health owns a 10 percent stake in the Macleay Valley-based licensed producer.

 

Cannabis - Will The Fortune 500 Join The Party?

 
Our Exclusive FREE Report Contains Information You NEED To Know About Cannabis Stock Investing!
 

As part of the new permit from Health Canada, the cannabis producer can also export medical cannabis extract products such as drops and sprays.

“We continue to prove the international viability of our highly differentiated cannabis health and wellness ecosystem with products, clinic operations, education and distribution,” Julian Fantino, Aleafia Health Chairman, said in the press release.

“With among the largest cultivation and extraction footprints in Canada coming online, we will continue to look to new international markets,” Fantino added.

Joshua Dennis, CEO of CannaPacific, said in a statement that the export license represented a significant milestone for the rapidly accelerating partnership between the two cannabis firms.

In a report published in 2018, New Frontier Data indicated that, while Australia represents one of the biggest cannabis markets in terms of revenues for the region, the medical space there is still in its infancy.

The research firm projected that the Australian medical base could grow to 330,000 patients by 2025, which would represent 1.2 percent of the country’s total population.

A projection from Statista places the value of the Australian medical cannabis market at AU$1.2 billion by 2024, up from AU$17.7 million in 2018.

In 2018, Health Canada said exports of medical cannabis product grew to 1,460 kilograms for dried flower and 920 liters of cannabis oil, according to a report from Marijuana Business Daily.

So far in 2019, the exporting of medical marijuana products from Canadian producers has continued to grow. Health Canada reported that 340 kilograms of dried flower and 195 litres of cannabis oil were exported during the first quarter of the year.

 

Cannabis - Will The Fortune 500 Join The Party?

 
Our Exclusive FREE Report Contains Information You NEED To Know About Cannabis Stock Investing!
 

Aleafia Health confirmed its investment in CannaPacific in November 2018. At the time, Dennis said the synergy between the two marijuana firms would capitalize on the emerging Australian medical market. The transaction closed in January 2019.

As part of its most recent quarterly results, the Canadian firm reported a net loss of C$20.2 million for Q1 2019, mainly attributed to a one time payment from the closing transaction for acquiring its fellow marijuana producer Emblem.

As of 3:49 p.m. EDT on Tuesday, shares of the Canadian cannabis producer rose just over 3 percent for a price per share of C$1.36. Aleafia Health reached the Toronto Stock Exchange in March 2019. The Toronto-based company does not have an Australian Stock Exchange listing.

Don’t forget to follow us @INN_Cannabis for real-time news updates!

Securities Disclosure: I, Bryan Mc Govern, hold no direct investment interest in any company mentioned in this article.

 

Cannabis - Will The Fortune 500 Join The Party?

 
Our Exclusive FREE Report Contains Information You NEED To Know About Cannabis Stock Investing!
 

Ayurcann Holdings Corp. (CSE: AYUR) (the “Company” or “Ayurcann”) an integrated Canadian extraction company specializing in the processing of cannabis and hemp for the production of oils and various derivative products, announces the granting of stock options and restricted share units.

The Company has announced that it has granted incentive stock options to directors, officers, employees and consultants of the Company to purchase an aggregate of 1,000,100 common shares under the Company’s Stock Option Plan. Each option is exercisable at a price of $0.16 per common share, expires three years from the date of grant and vest six months from the date of the grant.

Keep reading... Show less

A planned business merger between two leading cannabis producers hit a small delay this week as a critical vote got moved.

Meanwhile, a cannabis retail operator elected to celebrate 420 by auctioning a cannabis-themed digital art piece using blockchain technology.

Keep reading... Show less

Partnerships with Minardi Law , Minorities for Medical Marijuana, CultivatED, and the Georgia Justice Project will include clinics and virtual events across Florida , Georgia , and Massachusetts

Trulieve Cannabis Corp. (CSE: TRUL) (OTCQX: TCNNF) (“Trulieve” or “the Company”), a leading and top-performing cannabis company based in the United States announced today a series of expungment clinics located throughout south and central Florida as well as virtual events in Georgia and Massachusetts . The clinics are part of the Company’s celebration of the 50 th anniversary of 420.

Keep reading... Show less

Seth Rogen’s New Cannabis Brand are Now Available at Apothecarium Dispensaries in San Francisco , Berkeley and Capitola

The Apothecarium is offering cannabis from Houseplant, the cannabis lifestyle brand founded by Seth Rogen and Evan Goldberg at its five California dispensaries. The Apothecarium has three San Francisco locations (Castro, SOMA and Marina ) and one each in Berkeley and Capitola (outside of Santa Cruz ).

Keep reading... Show less